Back to Search Start Over

EXPLORATORY BIOMARKER ANALYSIS IN THE PH 3 ECHELON‐1 STUDY: WORSE OUTCOME WITH ABVD IN PATIENTS WITH ELEVATED BASELINE LEVELS OF SCD30 AND TARC.

Authors :
Radford, J.
Connors, J.M.
Younes, A.
Gallamini, A.
Ansell, S.M.
Kim, W.S.
Cheong, J.
Flinn, I.
Kalakonda, N.
Kaminski, M.
Pettengell, R.
Onsum, M.
Josephson, N.
Kuroda, S.
Liu, R.
Miao, H.
Gautam, A.
Trepicchio, W.L.
Sureda, A.
Source :
Hematological Oncology; Jun2019 Supplement S2, Vol. 37, p290-291, 2p
Publication Year :
2019

Subjects

Subjects :
ANTIBODY-drug conjugates
STOCK ownership

Details

Language :
English
ISSN :
02780232
Volume :
37
Database :
Complementary Index
Journal :
Hematological Oncology
Publication Type :
Academic Journal
Accession number :
137029564
Full Text :
https://doi.org/10.1002/hon.99_2630
Full Text Access
View/download PDF

Tools

Authors Abstract Subjects Details